Fever News and Research

RSS

Individuals without capacity excluded from potentially beneficial trials

Individuals who lack the capacity to consent to taking part in clinical trials could be missing out on the opportunity to receive potentially beneficial interventions, shows UK research.

11 Sep 2012

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Although people often say they have "strep" throat, most sore throats actually are caused by a virus, not streptococcus bacteria, and shouldn't be treated with antibiotics, suggest guidelines published by the Infectious Diseases Society of America (IDSA). Antibiotics are ineffective against viruses.

11 Sep 2012

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.

7 Sep 2012

Durata completes target enrollment in dalbavancin Phase 3 trials for abSSSI

Durata Therapeutics today announced that it has completed its target enrollment for DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response"), one of two ongoing, global, Phase 3 clinical trials of Durata's lead product candidate, dalbavancin, under investigation for the treatment of acute bacterial skin and skin structure infections (abSSSI).

7 Sep 2012

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Antibiotics are medicines used to treat infections or diseases caused by bacteria, such as some respiratory tract infections (including pneumonia and whooping cough), urinary tract infections, skin infections and infected wounds.

6 Sep 2012

WHO releases dengue strategy report, sets goal of cutting related deaths in half by 2020

"Saying dengue virus infections and deaths have mushroomed in recent years, the World Health Organization (WHO) recently released a strategy report that sets a goal of cutting deaths in half and reducing cases by 25 percent over the next eight years," CIDRAP reports.

6 Sep 2012

People need to protect themselves against West Nile virus

As this year's threat from the West Nile virus continues, one infectious diseases expert at the University of Alabama at Birmingham says a vaccine is not in our near future, so people need to protect themselves.

5 Sep 2012

Strong antiviral antibody response observed in oral administration of Flucide

NanoViricides, Inc. announced today that anti-influenza drug candidates under its FluCide program, when given orally, led to strong antiviral antibody response. The antibody response with Oral administration was stronger than that with IV administration and was substantially greater than that observed with oseltamivir.

5 Sep 2012

FDA approves Bosulif to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.

5 Sep 2012

Scientists succeed in clarifying molecular signature of hantaviruses

Scientists at Charité - Universitätsmedizin Berlin and Labor Berlin GmbH have succeeded in clarifying the molecular signature of the viruses that lead to an increasing size and number of hantavirus outbreaks in Germany.

3 Sep 2012

Western Schools offers new 4th Edition West Nile Virus continuing education course for nurses

West Nile virus is showing up earlier and producing more severe cases than normal this year, and nurses must be able to recognize who is at risk and how to best protect against it, an expert at Western Schools said today.

3 Sep 2012

Complacency and apathy may have played a role in recent spike of West Nile cases

With almost 1,600 cases of West Nile Virus and 66 mortalities reported to the Centers for Disease Control and Prevention (CDC) nationwide, officials are calling the recent West Nile virus outbreak the largest ever seen in the United States.

1 Sep 2012

Scientists identify specific role of RESA protein in modulating blood circulation

When the parasite responsible for malaria infects human red blood cells, it launches a 48-hour remodeling of the host cells. During the first 24 hours of this cycle, a protein called RESA undertakes the first step of renovation: enhancing the stiffness of the cell membranes.

31 Aug 2012

Flu virus can be passed on before appearance of symptoms

Research at Imperial College London examining influenza transmission in ferrets suggests that the virus can be passed on before the appearance of symptoms. If the finding applies to humans, it means that people pass on flu to others before they know they're infected, making it very difficult to contain epidemics.

30 Aug 2012

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

30 Aug 2012

Fever News and Research

Individuals without capacity excluded from potentially beneficial trials

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

Durata completes target enrollment in dalbavancin Phase 3 trials for abSSSI

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

WHO releases dengue strategy report, sets goal of cutting related deaths in half by 2020

People need to protect themselves against West Nile virus

Strong antiviral antibody response observed in oral administration of Flucide

FDA approves Bosulif to treat chronic myelogenous leukemia

Scientists succeed in clarifying molecular signature of hantaviruses

Western Schools offers new 4th Edition West Nile Virus continuing education course for nurses

Complacency and apathy may have played a role in recent spike of West Nile cases

Scientists identify specific role of RESA protein in modulating blood circulation

Flu virus can be passed on before appearance of symptoms

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Oral FluCide drug candidates effective in reducing lung viral load: NanoViricides

Children more likely to pick up stomach infections from private water supplies

Guidelines for parents to beat back-to-school bugs

Influenza virus can change microRNA expression to control immune responses in human lung cells

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News